Weight abnormal and Hyperhidrosis
Summary:
Hyperhidrosis is found among people with Weight abnormal, especially for people who are female, 50-59 old.
The study analyzes which people have Hyperhidrosis with Weight abnormal. It is created by eHealthMe based on reports of 335 people who have Weight abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Weight abnormal?
Weight abnormal is found to be associated with 1,698 drugs and 1,288 conditions by eHealthMe. Check the latest studies of Weight abnormal.
What is Hyperhidrosis?
Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,566 drugs and 3,538 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.
335 people who have Weight Abnormal and Hyperhidrosis are studied.

Gender of people who have Weight abnormal and experienced Hyperhidrosis *:
Age of people who have Weight abnormal and experienced Hyperhidrosis *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hyperhidrosis?
- Check whether Hyperhidrosis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Weight abnormal (2,837 reports)
- Hyperhidrosis (147,206 reports)
All the drugs that are associated with Hyperhidrosis:
- Hyperhidrosis (2,566 drugs)
All the conditions that are associated with Hyperhidrosis:
- Hyperhidrosis (3,538 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hyperhidrosis and Weight abnormal, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rocephin and Fentanyl Citrate - 5 seconds ago
- Could Zyrtec cause Urination - Painful? - 9 seconds ago
- Drug interactions of Ammonium Lactate and Cilostazol - 16 seconds ago
- Drug interactions of Zyprexa and Lansoprazole - 17 seconds ago
- Drug interactions of Enbrel and Qvar - 21 seconds ago
- Mepergan vs. Ambien, side effect and effectiveness comparison - 26 seconds ago
- Could Rebetol cause Liver Transplant Rejection? - 27 seconds ago
- Migraine in Morphine Sulfate, how severe and when it was recovered? - 29 seconds ago
- Could Palynziq cause Injection Site Reaction? - 30 seconds ago
- Drug interactions of Nystatin and Cefpodoxime Proxetil - 31 seconds ago